FIELD: biotechnology; dentistry.
SUBSTANCE: method for restoring or inhibiting dental erosion, promoting dental remineralization and/or enhancing anti-carious effects of fluoride includes applying to a tooth an oral care composition containing hydrophobin-like protein (hereinafter – HLP), having a polypeptide sequence selected from SEQ ID NO: 20 or SEQ ID NO: 22, and an orally acceptable carrier. HLP is present in the composition in the amount from 0.01 to 3 wt. % of the total weight of the composition. The oral care composition contains HLP having a polypeptide sequence selected from SEQ ID NO: 20 or SEQ ID NO: 22, if necessary, the effective amount of fluoride and an orally acceptable carrier. HLP is present in the composition in the amount from 0.01 to 3 wt. % of the total weight of the composition.
EFFECT: group of inventions is effective for restoring or mitigating effects of dental erosion, promoting dental remineralization and enhancing anti-carious effects of fluoride.
11 cl, 1 dwg, 4 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS AND METHODS FOR BIOLOGICAL PRODUCTION OF LACTATE FROM C1-COMPOUNDS USING TRANSFORMANTS OF LACTATE DEHYDROGENASE | 2014 |
|
RU2710714C2 |
| METHOD OF CONTROL OF HEART RHYTHM AND REDUCTION OF INDIVIDUAL CARDIOMYOCYTES USING THERMOGENETICS | 2022 |
|
RU2802995C1 |
| HERPES VACCINE | 2019 |
|
RU2731073C1 |
| NUCLEIC ACID CONSTRUCTIONS AND VECTORS FOR GENOTHERAPY FOR TREATING WILSON'S DISEASE AND OTHER CONDITIONS | 2015 |
|
RU2745567C2 |
| IMMUNO-INDUCING AGENT | 2016 |
|
RU2744843C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING MALIGNANT TUMOUR | 2016 |
|
RU2714205C2 |
| MATERIALS AND METHODS USED FOR TREATMENT OF RESPIRATORY DISEASES IN DOGS | 2020 |
|
RU2811752C2 |
| METHOD FOR PRODUCING L-AMINO ACIDS USING CORYNEBACTERIA USING GLYCINE CLEAVAGE SYSTEM | 2015 |
|
RU2713298C2 |
| METHOD OF PRODUCING PRECURSOR RENAL CELLS | 2016 |
|
RU2730861C2 |
| HIV-1 SUBTYPE A P17 PROTEIN ANTIBODIES | 2019 |
|
RU2727673C1 |
